The Oncology Institute Inc (TOI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 33,565 | 49,669 | 33,488 | 14,010 | 115,174 |
| Marketable Securities | N/A | N/A | 49,367 | 59,796 | N/A |
| Receivables | 59,320 | 48,681 | 42,911 | 40,433 | 21,244 |
| Inventories | 16,875 | 10,039 | 13,678 | 9,261 | 6,438 |
| TOTAL | $112,747 | $112,418 | $143,493 | $130,418 | $154,056 |
| Non-Current Assets | |||||
| PPE Net | 10,684 | 11,888 | 10,883 | 8,547 | 4,192 |
| Investments And Advances | 0 | 0 | 0 | 58,354 | 0 |
| Intangibles | 18,245 | 22,040 | 25,134 | 39,375 | 44,871 |
| Other Non-Current Assets | 22,980 | 26,371 | 29,730 | 24,971 | 320 |
| TOTAL | $51,909 | $60,299 | $65,747 | $131,247 | $49,383 |
| Total Assets | $164,656 | $172,717 | $209,240 | $261,665 | $203,439 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 183 |
| Accounts payable and accrued liabilities | 43,167 | 24,324 | 14,429 | 9,372 | 15,559 |
| Accrued Expenses | 20,639 | 21,093 | 13,996 | 14,595 | 13,924 |
| TOTAL | $70,962 | $52,215 | $34,788 | $29,720 | $29,798 |
| Non-Current Liabilities | |||||
| Long Term Debt | 77,400 | 93,131 | 86,826 | 80,621 | N/A |
| Other Non-Current Liabilities | 32,014 | 23,750 | 30,569 | 28,041 | 69,111 |
| TOTAL | $109,414 | $116,913 | $117,427 | $108,770 | $69,482 |
| Total Liabilities | $180,376 | $169,128 | $152,215 | $138,490 | $99,280 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 98,839 | 75,753 | 74,313 | 74,552 | 73,249 |
| Common Shares | 10 | 8 | 8 | 7 | 7 |
| Retained earnings | -271,419 | -210,813 | -146,150 | -63,082 | -63,234 |
| Other shareholders' equity | -19 | -19 | -19 | 0 | 0 |
| TOTAL | $-15,720 | $3,589 | $57,025 | $123,175 | $104,159 |
| Total Liabilities And Equity | $164,656 | $172,717 | $209,240 | $261,665 | $203,439 |